| Patents for A61P 33 - Antiparasitic agents (21,787) |
|---|
| 07/18/2002 | WO2001072728A3 Novel piperazine derivatives |
| 07/18/2002 | WO2001066747A3 Proteins named fctrx and nucleic acids encoding same |
| 07/18/2002 | WO2001005834A9 Human tumor necrosis factor receptors tr13 and tr14 |
| 07/18/2002 | US20020095033 Monocyclic L-nucleosides, analogs and uses thereof |
| 07/18/2002 | US20020095023 Membrane protein for use in the treatment of allergies, parkinson's, alzheimer's and apoptitic defects |
| 07/18/2002 | US20020094955 Plasminogen-like polynucleotides, polypeptides, and antibodies |
| 07/18/2002 | US20020094323 Administration of reactive oxygen species inhibitor or scavenger and at least one monocyte maturation-promoting agent |
| 07/18/2002 | CA2433981A1 Mikanolide derivatives, their preparation and therapeutic uses |
| 07/18/2002 | CA2432350A1 Method for inhibiting the expression of a target gene |
| 07/17/2002 | EP1222921A1 Pharmaceutical compositions of tizoxanide and nitazoxanide |
| 07/17/2002 | EP1222308A1 Antiprotozoal histone acetyl transferase inhibitors |
| 07/17/2002 | EP1222270A2 Proteins and polynucleotides encoded thereby |
| 07/17/2002 | EP1222209A2 Modulation of t cell differentiation for the treatment of t helper cell mediated diseases |
| 07/17/2002 | EP1222200A1 Vaccine |
| 07/17/2002 | EP1221908A1 Oral pharmaceutical compositions containing taxanes and methods of treatment employing the same |
| 07/17/2002 | EP1221845A1 Active ingredient combinations having insecticidal and acaricidal properties |
| 07/17/2002 | EP0915857B1 Compounds of the 3-aryl 2,4 dioxo oxazolidine family and use thereof in cosmetics and pharmaceuticals |
| 07/17/2002 | EP0815450B1 Compounds and methods for the dectection of t. cruzi infection |
| 07/16/2002 | US6420591 Carbamates and compositions thereof, and methods for their use for treating cancer, inflammation, or a viral infection |
| 07/16/2002 | US6420540 Toxoplasma gondii antigens |
| 07/16/2002 | US6420536 4″-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives |
| 07/16/2002 | US6420414 Amino derivatives of EM-138 and methods of treating angiogenesis with same |
| 07/16/2002 | US6420373 9-N-Bicyclic nuceoside agents useful as selective inhibitors of proinflammatory cytokines |
| 07/16/2002 | US6420372 Tropical malarial antiprotozoan |
| 07/16/2002 | US6420370 Pyrimidine derivatives and method of making and using derivatives |
| 07/16/2002 | US6420342 Ribose, folic acid, orotic acid |
| 07/16/2002 | US6420160 Expression vector for use in immunotherapy and gene therapy |
| 07/16/2002 | US6419925 Toxoplasma gondii antigens, the preparation thereof and the use thereof |
| 07/16/2002 | CA2159730C Ionene polymers as anthelmintics in animals |
| 07/11/2002 | WO2002053519A2 Hydrophobic polyamine analogs and methods for their use |
| 07/11/2002 | WO2002053138A2 Treatment for inhibiting neoplastic lesions using incensole and/or furanogermacrens |
| 07/11/2002 | WO2002053132A1 Water-soluble powdery or granular compositions based on phenanthridines and their uses |
| 07/11/2002 | WO2002053130A2 Sustained release drug delivery devices with coated drug cores |
| 07/11/2002 | WO2002053110A2 Pharmaceutical preparation for douches and/or irrigations of natural or pathological cavities in the human body |
| 07/11/2002 | WO2002053100A2 Pharmaceutical dosage form for oral administration of low molecular weight heparin |
| 07/11/2002 | WO2002052934A2 Pesticidal and antiparasitic compositions |
| 07/11/2002 | WO2002030410A3 Suppression of cyclin kinase activity for prevention and treatment of infections |
| 07/11/2002 | WO2002014511A3 Regulation of human p2y1-like g protein-coupled receptor |
| 07/11/2002 | WO2001076556A3 Lipid-based drug delivery systems against parasitic infections |
| 07/11/2002 | WO2001046443A3 Proteases |
| 07/11/2002 | WO2001034205A3 Use of lytic toxins and toxin conjugates |
| 07/11/2002 | WO2000073263A9 Cytofectin dimers and methods of use thereof |
| 07/11/2002 | US20020091136 Pharmaceutical compositions containing cinchonine dichlorhydrate |
| 07/11/2002 | US20020090387 Insecticidal combination to control mammal fleas in particular fleas in particular fleas on cats and dogs |
| 07/11/2002 | US20020090375 Stratified and cryogenically stored vaccines, process for their preparation |
| 07/11/2002 | US20020090365 For therapy of vaginal and gastrointestinal infections |
| 07/11/2002 | CA2433552A1 Pharmaceutical preparation for douches and/or irrigations of natural or pathological cavities in the human body |
| 07/10/2002 | EP1220657A1 Liposome encapsulated silver salt compositions |
| 07/10/2002 | EP0812206B1 Cd40 binding protein for stimulating an immune response |
| 07/10/2002 | CN1358188A Diphosphate salt of A4'-substituted-9-deoxo-9A-aza 9A-homoerythromycin derivative and its pharmaceutical composition |
| 07/10/2002 | CN1357351A Cysticercosis treating medicine |
| 07/10/2002 | CN1087168C Compound with cooperation of anti-malaria |
| 07/09/2002 | US6416779 Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections |
| 07/09/2002 | CA2270124C 9a,11b-dehydro derivatives of 9-oxime-3-keto-6-0-methylerythromycin |
| 07/09/2002 | CA2244519C C-4":substituted macrolide antibiotics |
| 07/04/2002 | WO2002052002A2 Immunomodulatory polynucleotides and methods of using the same |
| 07/04/2002 | WO2002051835A1 Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives |
| 07/04/2002 | WO2002051410A2 Phenylthiazole and thiazoline derivatives and their use as antiparasitics |
| 07/04/2002 | WO2002051233A2 Universal antimicrobial treatment |
| 07/04/2002 | WO2002017917A8 Manzamines for treatment of drug resistant infection |
| 07/04/2002 | WO2002012346A8 A new slit-like protein obtained from a cdna library from hs-5 stromal cell line |
| 07/04/2002 | WO2001091535A3 A combination kit used in the treatment of malaria containing chloroquine and 3-(1-(((4-((6-methoxy-8-quinolinyl)amino)pentyl)amino)-ethylidene)-dihydro-2(3h)furanone enthält |
| 07/04/2002 | WO2001078768A3 Targeted vaccine delivery systems |
| 07/04/2002 | US20020086996 N-cyanomethyl amides which are cysteine protease inhibitors; treating osteoporosis; mixtures with bisphosphonates |
| 07/04/2002 | US20020086891 Substituted benzo(b)thiophenes or benzoisothiazoles which inhibit 2,3-oxidosqualene-lanosterol cyclase which is required for the biosynthesis of cholesterol, ergosterol and other sterols |
| 07/04/2002 | US20020086051 For delivering drug directly to interior portions of the body of a mammalian organism, such as to the eye |
| 07/04/2002 | US20020086031 Compositions and vaccines containing antigen(s) of cryptosporidium parvum and of another pathogen |
| 07/04/2002 | DE10063294A1 New N-(heterocyclyl-alkyl)-fused norbornylamine derivatives, are NHE3 inhibitors useful e.g. for treating respiratory disorders, renal failure, intestinal dysfunction, lipid metabolism disorders or proliferative diseases |
| 07/04/2002 | CA2430691A1 Immunomodulatory polynucleotides and methods of using the same |
| 07/03/2002 | EP1218544A1 Methods for identifying rna binding compounds |
| 07/03/2002 | EP1218540A2 Transposon mediated differential hybridisation |
| 07/03/2002 | EP1218403A2 Combinatorial synthesis of libraries of macrocyclic compounds useful in drug discovery |
| 07/03/2002 | EP1218333A1 Anti-inflammatory nitro- and thia- fatty acids |
| 07/03/2002 | EP1218000A1 Anti-cancer nitro- and thia-fatty acids |
| 07/03/2002 | CN1356986A Spiroimidazolidine derivatives, their prepn. their use and pharmaceutical prepns. comprising them |
| 07/03/2002 | CN1356907A Fish serine proteinases and their pharmaceutical and cosmetic use |
| 07/03/2002 | CN1356902A IL-8 receptor antagonists |
| 07/03/2002 | CN1356899A IL-8 receptor antagonists |
| 07/03/2002 | CN1356875A Method of using emamectin to treat fish parasites |
| 07/03/2002 | CN1356120A Instant particles 'Daozhihuachong' and its preparing process |
| 07/02/2002 | US6414115 Parasitic nematode transglutaminase proteins and uses thereof |
| 07/02/2002 | US6414013 Thiophene compounds, process for preparing the same, and pharmaceutical compositions containing the same background of the invention |
| 07/02/2002 | US6413993 Combination preparation for treating malaria |
| 07/02/2002 | US6413936 Glycomimetics as selectin antagonists and pharmaceuticals having antiinflammatory activity |
| 07/02/2002 | US6413731 Methods of screening for compounds which bind to a human SNORF36A receptor |
| 07/02/2002 | CA2229173C Parasiticidal pyrazole derivatives |
| 07/02/2002 | CA2223699C In ovo vaccination against coccidiosis |
| 06/27/2002 | WO2002050079A1 Cyclin-dependent kinase (cdk) and glycolene synthase kinase-3 (gsk-3) inhibitors |
| 06/27/2002 | WO2002049641A2 Anti-endoparasitic amidoacetonitrils |
| 06/27/2002 | WO2002049633A2 Use of amidoamines to treat or prevent acanthamoeba and fungal infections |
| 06/27/2002 | WO2002049627A2 Antifungal compositions containing an antibiotic and one or more amidoamines |
| 06/27/2002 | WO2002049576A2 Fab i and inhibition of apicomplexan parasites |
| 06/27/2002 | WO2001014536A3 Nucleic acid molecule comprising a nucleic acid sequence which codes for a haemocyanin, and comprising at least one intron sequence |
| 06/27/2002 | US20020082289 Fipronil amidated with a carboxylic acid having organic radical E which is enantiomerically enriched; preparing (S)-fipronil which has reduced emetic activity in animals (for oral flea and tick control) |
| 06/27/2002 | US20020081292 Anthelmintic composition |
| 06/27/2002 | US20020081290 Protein kinase homologs |
| 06/27/2002 | CA2432992A1 Fab i and inhibition of apicomplexan parasites |
| 06/27/2002 | CA2432417A1 Cyclin-dependent kinase (cdk) and glycolene synthase kinase-3 (gsk-3) inhibitors |
| 06/26/2002 | EP1037609A4 Aqueous insecticidal pour-on formulation |
| 06/26/2002 | EP0692963B1 Use of terbinafine for the therapeutic treatment of pneumocystosis |